Clinical Trials Browser

Phase 1 × proxalutamide × Genitourinary × Clear all

NCT02826772 2020-03-17

Safety, Tolerability, and PK of GT0918 (Proxalutamide) in Subjects With Metastatic Castrate Prostate Cancer

Phase 1 Completed

Metastatic Castrate Resistant Prostate Cancer (mCRPC)